v" The present investigation was conducted to examine the effects upon normal lymphocyte activation of the addition of brain-tumor cyst fluid or cerebrospinol fluid (CSF) to an in vitro culture system. It was believed that factors present in these fluids may play a role in local and systemic immunosuppression in brain-tumor patients. The authors evaluated the effect of the cyst fluid, CSF, and serum from eight patients with brain tumors (one astrocytoma, five glioblastoma multiforme, one medulloblastoma, and one microglioma) on mitogen-stimulated lymphocyte function as measured by 3H-thymidine incorporation, cell size distribution, and cellular proliferation. Lymphocytes from normal volunteers were incubated for 90 hours in culture medium with 10% pooled human serum, mitogens (phytohemagglutinin, concanavalin A, and pokeweed mitogen), and a range of volumes of cyst fluid or CSF from the tumor patients. Significant suppression of mitogen-induced activation of the lymphocytes was demonstrated in the presence of cyst fluid from five out of six patients, but the mitogen response was only minimally affected by the addition of the CSF from these patients to the culture medium. The suppression of lymphocyte activation by cyst fluid was directly proportional in several cases to tile concentration of the cyst fluid. The total protein, albumin, and immunoglobulin (Ig) concentrations in the cyst fluids were observed to roughly correspond to the serum levels and were much higher than in CSF. These studies suggest that brain-tumor cells locally produce lymphocyte-suppressive factors which may then be released into blood. Preliminary characterization of the suppressive factor(s) responsible for the inhibition of lymphocyte function indicates that they are non-dialyzable and do not appear to be an IgG.
D
EPRESSED cell-mediated immunity has been well documented by a number of investigators in patients with intracranial neoplasms, as evidenced by impaired in vivo skin test reactivity and/or decreased in vitro lymphocyte responsiveness to either mitogens or antigens. 3-5'13'~9'22 '24 Neuwelt, et al., 18 have reported data indicating that the depressed cell-mediated immunity is due to both serum factors and an intrinsic defect in T-lymphocyte function. The same authors ~7"~8 have suggested that phenytoin, barbiturates, and steroids may contribute to the depressed cellular immunity seen in brain-tumor patients. Other investigators have implicated immunoglobulins a or alphaglobulins 6 as being responsible for this defective cellmediated immunity. McKeever, et al., ~2 are evaluating several proteins produced and released by cultured human astrocytoma cells to see if they can function as immunoregulators. Mahaley, et al., m observed a quantitative decrease in the number of T-cells in the circulating lymphocyte population of brain-tumor patients. Other reports 2,23 have suggested that suppressor cells (T-lymphocytes or monocytes) in the peripheral blood from brain-tumor patients may be associated with the impairment of the immune response in this patient population. The depression of cell-mediated immunity in brain-tumor patients has been reviewed. 7 '8,~s The present investigation was conducted to examine the effects of tumor cyst fluid, cerebrospinal fluid (CSF), and serum from brain-tumor patients upon mitogeninduced normal lymphocyte activation in an in vitro culture system. These studies were designed to ev~uate the hypothesis that such fluids contain locally produced immunosuppressive factors that may be released by the tumor into the serum and/or CSF.
Materials and Methods

Preparation of Samples
Tumor cyst fluid, CSF, and serum was obtained during surgery from eight patients with primary intracranial neoplasms who underwent operations at the Oregon Health Sciences University and Veterans Administration Hospitals. Authorization was given by the institutional human research committees. The characteristics of these patients are shown in Tables 1 to 5 . The test fluids were centrifuged at 500 G for 10 minutes, filtered through a 0.2-#m filter,* and stored at -70~
To obtain normal human lymphocytes, 30 ml of peripheral blood was withdrawn into heparinized blood collection tubes from healthy volunteers. The blood was then diluted 1:3 with 0.9% sterile normal saline. Aliquots of 40 ml of the blood-saline mixture were placed in 50-ml polypropylene conical tubes and FicollHypaque (10 ml) was layered below the blood-saline mixture.3-After centrifugation at 200 G for 45 minutes at room temperature, the cloudy lymphocyte-rich layer at the plasma-Ficoll-Hypaque interface was removed by aspiration and washed three times in sterile normal saline. The cells were resuspended in Roswell Park Memorial Institute (RPMI) 1640 culture medium supplemented with L-glutamine (2 mM/ml), penicillin (200 units/ml), streptomycin (200 #g/ml), and gentamicin (10 #g/ml). This is hereafter referred to as "complete RPMI 1640 culture medium." The cells were then counted on a ZBI Coulter counter~ and further suspended to give a final concentration of 5 • l0 4 cells/ 200 ul for a microtiter culture system and 1 x 10 6 cells/ 1.6 ml for a tube culture system in complete RPMI 1640 culture medium with 10% (v/v) heat-inactivated (at 560C for 30 minutes) normal pooled human serum (PHS). It should be noted that after the addition of tumor cyst fluid, CSF, or their control fluids (PHS or saline, respectively), the final serum concentration ranged from 8% to 23% in each culture.
Serum was obtained from those normal volunteers whose lymphocytes were used in our control tissue culture studies; blood types included A+, B+, and AB+. The PHS was compared to 10% fetal bovine serum in an initial series of microtiter culture experiments. Incorporation of 3H-thymidine into DNA (deoxyribonucleic acid) as quantitated in counts per minute (cpm) was slightly although consistently higher with the addition of PHS. The cellular morphology of the peripheral blood mononuclear cell suspension was evaluated by examining Wright-stained smears, and viability was determined by the trypan blue dye exclusion tech-* Filters manufactured by Gelman Sciences, Inc., Ann Arbor, Michigan. 
Assessment of Mitogen-Induced Lymphocyte Activation
Assays for in vitro lymphocyte responsiveness to mitogens were carried out using three parameters as follows: 1) 3H-thymidine incorporation into DNA; 2) cell size distribution analysis; and 3) cellular proliferation. Incorporation of 3H-thymidine into DNA was evaluated using a microtiter culture system. Cell size distribution and cellular proliferation were evaluated on a ZBI Coulter counter and Coulter channelyzerw using a tube culture system.
Lymphocyte Culture for Analysis of 3H-Thymidine Incorporation
Mononuclear cells (5 x 104) in 200 ul of complete RPMI 1640 culture medium containing 10% (v/v) heatinactivated (at 56~ for 30 minutes) PHS were cultured in triplicate using round-bottom microtiter plates. An optimal concentration of either phytohemagglutinin (PHA: 5.0 ~zg/ml), concanavalin A (Con A: 250 ug/ml), or pokeweed mitogen (PWM: 25/sg/ml)j[ was added in a volume of 20 #1. In addition, tumor cyst fluid, CSF, or serum from tumor patients were tested for their ability to inhibit lymphocyte proliferation in response to the mitogens by adding 40 ul of the test fluids to triplicate wells of the microtiter plates. Control responses were obtained from triplicate tests to which an additional 40 ~zl of normal PHS, normal CSF (obtained at myelography for lumbar disc disease), or normal saline was added in addition to the standard concentration of PHS (10% v/v) and other nutrients. In titrating the inhibitory activity of the test fluids, a range of volumes (40, 30, 20, or 10 tA) of the tumor cyst fluid, CSF, or patients' sera were added to each at the initiation of the culture, with the volumes being equalized by addition of 0.9% sterile normal saline. The final volume in each well was 260 ~,1. Cell cultures were incubated at 37~ in a humidified atmosphere containing 5% CO2 and 95% air for 72 hours. Then 1.0 izCi of 3H-thymidine (specific activity 6.7 Ci/mmole) was added to each well. At 90 hours, the cells were harvested on glass-fiber filters with an automatic multiple-sample harvester.* The filter disc was processed in Aquasol, a cocktail for liquid scintillation counting, and radioac- 
Lymphocyte Culture for Evaluating Cell Size and Proliferation
For evaluation of cell size (blastogenesis) and proliferation, lymphocyte cultures were conducted in duplicate tubes prepared simultaneously with the microtiter plate cultures. Mononuclear cells (1.0 • 106) were suspended in 1.6 ml of complete RPMI 1640 culture medium containing 10% (v/v) heat-inactivated normal PHS, and the suspension was placed in sterile 17 x 100-mm polypropylene culture tubes. The PHA (0.2 ml, 5 ug/ml) and then test fluids (tumor cyst fluid, serum, or CSF) were added at various volumes (0.2, 0.15, 0.1, and 0.05 ml/tube). The final volume (2.0 ml) was equalized by the addition of 0.9% sterile normal saline. Control cultures containing normal PHS or normal CSF instead of tumor cyst fluid or patient CSF were also prepared as in the microtiter cultures. Cell size distribution as well as cellular proliferation was evaluated on a ZBI Coulter counter and Coulter channelyzer after 90 hours of incubation at 37~ in a humidified atmosphere of 5% CO2 and 95% air.
Evaluation of Cell Size Distribution
The Coulter counter and Coulter channelyzer were set as follows to evaluate each experimental culture for cell size distribution: aperture size, 100 ~; amplification, ~; 1/aperture current, 89 lower threshold, 20; upper threshold, 100; base channel threshold, 20; window width, 100; count range, 1K; and count control, stop at full scale. With these settings, our preliminary studies indicated that the vast majority (approximately 90%) of cultured but unstimulated normal human lymphocytes were observed between Channels 1 and 19. 
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osized) Coulter microspheres. Since the average particle volume of the monosized system is a known factor, the calibration constant and the threshold factors can be calculated. The threshold factor represents the value of each threshold dial division in microns and can be converted to diameter.
Evaluation of Cell Proliferation
Accurate counts for mononuclear cells were accomplished on a ZBI Coulter counter by adding Zap-Oglobin II~ to lyse the cell membrane so that only nucleated cells were counted. To count cells, the Coulter counter settings were as follows: amplification, ~; aperture size, 100 #; 1/aperature current, 89 lower threshold, 2; and upper threshold, 27. Cell proliferation was calculated by averaging multiple counts for each culture sample and calculating a proliferation ratio by dividing the number of cells in each experimental culture by the number of cells in the control samples containing no mitogen.
Analysis of Cyst Fluid and CSF from Tumor Patients
Tumor cyst fluid from four brain-tumor patients was analyzed for total protein content and for its composition using the standard biuret test and protein electro~ phoresis. Quantitative measurements of immunoglobulin (Ig)G, IgA, and IgM of cyst fluid and CSF were evaluated by laser nephelometry.w z~ The phenytoin level of tumor cyst fluid was measured by enzyme immunoassayll at the time the cyst fluid was evaluated.' The lower limits of sensitivity of these assays are 0.1 mg/dl for immunoglobulins and 2.5 ug/ml for phenytoin. These evaluations were performed in the clinical laboratory at the Veterans Administration Hospital, Portland, Oregon.
To determine if any of the inhibitory factor(s) were dialyzable, 1.0 ml of tumor cyst fluid was dialyzed against several changes of 0.9% normal saline during a 24-hour period at 4~ The dialysis tubing has a 24-A pore radius and allows the passage of molecules of less than 12,000 to 14,000 daltons. The dialysates were sterilized by passing through a 0.2-1zm filter. Normal lymphocyte activation in response to mitogens was evaluated as described earlier, using both original and dialyzed tumor cyst fluid to see if there was any change in its inhibitory effect on lymphocyte function.
Since Protein A (a constituent of the cell wall of The Protein A gel suspension (1.0 ml) was mixed with 1.0 ml of tumor cyst fluid at 20~ for 30 minutes. After centrifugation at 500 G for 15 minutes at room temperature, the supernatant was removed and assayed for IgG content by laser nephelometry. Plain Sepharose 4B was simultaneously used as a control material under the same conditions in order to examine how much nonspecific binding of IgG to Sepharose 4B would take place. After dialysis against a 0,1 N phosphate buffer solution, IgG-depleted cyst fluid was sterilized by passing through a 0.2-urn filter. Normal lymphocyte activation in response to mitogens was evaluated as described earlier using both control (exposed to Sepharose 4B) and IgG-depleted (exposed to Protein A Sepharose 4B) cyst fluid to see if there was any change in the inhibitory effect on lymphocyte function. Approximately 98% of the IgG fraction in the cyst fluid was depleted by the Protein A Sepharose 4B suspension. This proportion of IgG is higher than the 85% removal usually seen with Protein A and may represent nonspecific binding to the Sepharose.
Results
Composition of brain-tumor cyst fluid
An aliquot of brain-tumor cyst fluid from four patients was subjected to protein electrophoresis ( Table  1 ). The total protein content and composition of tumor cyst fluid are similar to but quantitatively less than those of serum. Similarly, the globulin content of tumor cyst fluid is similar to that of serum. Thus, normal PHS was used instead of cyst fluid as a control material throughout these studies, and physiological saline was used as a control for CSF. The addition of varying quantities of brain-tumor cyst fluid resulted in an increased protein content in each experimental culture. Therefore, in the control cultures, the serum content ranged from 18% to 23% instead of 8%. The increased serum content of these control cultures did not affect DNA synthesis, blastogenesis, or lymphocyte proliferation. Thus, the effects of tumor cyst fluid on lymphocyte proliferation are due to the presence of a factor other than normal serum protein.
Quantitative measurements of IgG, IgA, and IgM in tumor cyst fluid and CSF were also performed ( Table  2) . These immunoglobulins were found in tumor cyst fluid in relatively high quantities as compared to their levels in CSF.
With regard to phenytoin concentration in cyst fluid, three different samples of cyst fluid were measured. Among them, the highest level was 13.0 ug/ml, which corresponds to the final concentrations of 2.0 ~g/ml in each microtiter well and 1.3 ug/ml in the tube culture system. On the basis of previous in vitro studies,17 these levels are too low for phenytoin to be the suppressive factor. Tables 3, 4 , and 5 show the effects of tumor cyst fluid, CSF, and serum on 3H-thymidine incorporation ~t Percent suppression = control response -response to CSF x 100/control response. w Suppression was statistically significant (p < 0.05) as determined by Student's t-test.
Effect of Cyst Fluid, CSF, and Serum on MitogenInduced Lymphocyte Activation
Immunosuppressive factors in tumor cysts
into DNA of mitogen-stimulated normal h u m a n lymphocyte cell cultures. The data are expressed in terms of mean incorporation of 3H-thymidine per minute (cpm) _+ standard error of the mean in the presence or absence of the test fluid. The suppression of 3H-thymidine incorporation ranged from 63% to 94% in the presence of t u m o r cyst fluid in five of six cases when compared to the control cultures containing heat-inactivated PHS instead of t u m o r cyst fluid ( Table 3 ). The inhibitory activity of cyst fluid was dose-dependent in three of the four cases studied (Tables 6 and 7) ; that is, the suppression of mitogen-induced lymphocyte activation by cyst fluid increased in direct proportion to the concentration of the cyst fluid present in microtiter wells. The cyst fluid from one of the patients (Case 2) markedly suppressed lymphocyte activation to all the mitogens (PHA, Con A, and PWM). In all other patients, the effects of t u m o r cyst fluid were less apparent with Con A and P W M than with PHA (Table 3) .
In contrast to cyst fluid, CSF from brain-tumor patients had only a m i n i m a l a m o u n t of suppressive effect on mitogen-induced normal lymphocyte activation (Table 4 and Fig. 1 ). Serum from b r a i n -t u m o r patients had an inhibitory activity on mitogen-induced lymphocyte activation that was between the inhibitory activity of cyst fluid and CSF (Fig. 1) . Dose-response studies of the inhibitory effects of serum showed similar trends as with cyst fluid obtained from the same patient, even though the effects were much more prominent with cyst fluid (Fig. 2) .
The possibility that inhibitory factors might bind mitogens rather than affect lymphocyte function di- rectly was also examined. Mitogens were added at various concentrations to give both optimal and suboptimal stimulation. Figure 3 shows that the entire response to PHA was completely suppressed by the presence of tumor cyst fluid, and the pattern of the PHA doseresponse curve was exactly identical in the presence or absence of cyst fluid. A similar trend was observed in dose-response curves with Con A and PWM. This indicates that cyst fluid affects lymphocytes directly rather than by binding to (inactivating) mitogens. Heat stability of inhibitory factors was also evaluated (the results not shown) to see if the mechanism of suppression may involve complement. The inhibitory effect of tumor cyst fluid was not lost by heat treatment at 56~ for 30 minutes.
Effect of Cyst Fluid and CSF on Cell Volumes
Cell distribution analysis was performed on the Coulter channelyzer with the settings described in the Materials and Methods section using cells cultured in tubes rather than microtiter plates. As shown in Table 6 , following 90 hours of incubation in the presence of PHA, approximately 75 % of normal lymphocytes were found between Channels 20 and 100, corresponding to a cell diameter of between 10.80 u and 15.58 u. In four cases, at least a suggestion of dose-dependent suppression by brain-tumor cyst fluid of lymphocyte activation was observed, as in the studies of DNA synthesis de- t Activated lymphocytes are those cells assigned to Channels 20 to 100 on the Coulter channelyzer. The percentage of cells above Channel 20 is referred to as percent activated lymphocytes. Control response (%): 9.6 _+ 0.5 for no phytohemagglutinin (PHA); 75.8 _+ 1.2 for PHA + 0.2 ml normal saline + complete culture medium; and 73.3 + 2.8 for PHA + 0.2 ml pooled human serum + complete culture medium (mean percentages _+ standard error of the mean in eight samples). t The proliferation ratio was calculated by dividing the cell number in each experimental culture by the number of cells in the control culture which contained no phytohemagglutinin (PHA). Control response: 1.0 for no PHA; 2.41 + 0.13 for PHA + 0.2 ml normal saline + complete culture medium; and 2.50 + 0.19 for PHA + 0.2 ml pooled human serum + complete culture medium (mean ratios + standard error of the mean in eight samples).
scribed above. As illustrated in Fig. 4 , increasing volumes of cyst fluid inhibited blastogenesis (that is, increase in cell size) just as with D N A synthesis. For example, 10% cyst fluid (v/v) decreased the percent of activated lymphocytes from 73.3% to 50.5%, whereas 3H-thymidine incorporation decreased from 75,000 to 24,000 cpm with 10% t u m o r cyst fluid in the culture medium.
Lffect o f Cyst Fluid a n d C S F on Mitogen-S t i m u l a t e d Cellular Proliferation
An increase in cell number, designated here as cellular proliferation, is another measure of lymphocyte activation. A proliferation ratio was calculated by dividing the n u m b e r of cells in each experimental culture by the n u m b e r of cells in control culture that contained no PHA. As shown in Table 7 , the proliferation ratio for control cultures containing PHA, but no test fluid (tumor cyst fluid or patient CSF), was found to be approximately 2.5. Three out of four experimental cultures that contained a range of volumes of cyst fluid demonstrated dose-related suppression of lymphocyte proliferation.
Cyst fluid from one patient (Case 2) produced the greatest degree of suppression of lymphocyte activation, whereas in another patient (Case 8) there was no evidence of suppressed cellular proliferation as measured by the proliferation ratio. Again, the dose-related inhibitory activity of cyst fluid on lymphocyte proliferation as evidenced by this method (Table 7) 
Effects of Dialysis and IgG Depletion of Cyst Fluid on Mitogen-Induced Lymphocyte Activation
Cyst fluids (1.0 ml) from three patients (Cases 1, 2, and 3) with brain tumors were dialyzed against several changes of 0.9% normal saline (a total of 3 liters) for 24 hours at 4~ and then tested for their ability to inhibit the PHA response of normal lymphocytes. Dialysis of the cyst fluid from three patients did not result in significant loss of inhibitory activity (mean suppression 63% _+ 15%) compared to that of the original untreated fluid (60% _+ 16% suppression).
In addition, IgG depletion of cyst fluid by Protein A Sepharose 4B resulted in only minimal loss of inhibitory activity. Approximately 98% of IgG removal was achieved in each experiment, and yet IgG-depleted cyst fluid still inhibited 77% of mitogen-induced lymphocyte activation in comparison to 86% suppression with cyst fluid exposed to Sepharose 4B to which no Protein A was bound. It is therefore unlikely that the IgG fraction of cyst fluid is responsible for inhibition of lymphocyte activity.
Discussion
In this series of experiments, brain-tumor cyst fluid markedly suppressed mitogen-induced lymphocyte activation, in contrast to CSF from brain-tumor patients which demonstrated little effect. Matsukado and Uemura ~ were not able to detect any "blocking" activity in CSF. Serum from brain-tumor patients suppressed lymphocyte activation, but to a much lesser extent than cyst fluid. Brain-tumor cyst fluid not only suppressed the incorporation of a radiolabeled pyrimidine nucleoside (3H-thymidine) into DNA in cultured lymphocytes, but also inhibited the process of blastogenesis (increase in cell volume) and cell division/cell proliferation. The suppression of lymphocyte activation induced by the cyst fluid was dose-related in three or four of the six samples of tumor cyst fluid studied.
The total protein, albumin, and immunoglobulin concentrations in cyst fluid were found to correspond to normal human serum; however, normal serum had no suppressive activity (as evaluated in our microtiter studies using increasing concentrations of PHS), and serum from brain-tumor patients was much less suppressive than brain-tumor cyst fluid. It is also clear from the current studies that the suppression of mitogeninduced lymphocyte activation results from the direct interaction between a factor in cyst fluid and lymphocytes, rather than from binding of the suppressive factor(s) in cyst fluid to PHA. These results suggest that the immunosuppressive factor(s) is produced and secreted by the tumor cells and released into tumor cyst fluid and subsequently into the systemic circulation. The gradient of immunosuppressive activity of tumor cyst fluid and serum suggests that at least some of the previously reported serum "blocking" factors 3-5' 24 may originate directly from tumor. Another less likely explanation is that the immunosuppressive factor(s) is con-K. Kikuchi and E. A. Neuwelt centrated in tumor cyst fluid, since the major protein content of brain-tumor cyst fluid may be a transudate from serum. J4 Interestingly, only minimal immunosuppressive factors were detected in CSF.
The present report also demonstrated that mitogen activation induced by Con A and PWM in the presence of tumor cyst fluid was less affected than the PHAinduced lymphocyte response. This could indicate that the suppressor factor(s) present in cyst fluid competitively binds to PHA receptor(s) but not to Con A or PWM receptors on the surface of peripheral T-cells. Both PHA and Con A are T-cell mitogens that can activate different subpopulations of T-cells, whereas PWM is a mixed T-and B-cell mitogen. 2~ Thus, the suppressive factor(s) could prevent activation of a subpopulation of T-cells normally activated by PHA but which are not activated by Con A or PWM.
Previous studies from our laboratory~7'18 showed that significant depression of in vitro lymphocyte responsiveness occurred with exposure to two anticonvulsant agents (phenytoin and, to a much lesser degree, phenobarbital). In the present investigation, however, the maximum final concentration of phenytoin (from cyst fluid) in the culture systems was 2.0 ~g/ml, which is far below the level that could explain the lymphocyte suppression observed with cyst fluid.
With regard to the preliminary characterization of the suppressive factor(s) present in tumor cyst fluid, the suppressive factor(s) does not seem to be dialyzable and thereby has a molecular weight greater than 12,000. On the basis of our studies with Protein A, which removed IgG from cyst fluid, it is unlikely that the IgG fraction of tumor cyst fluid is directly involved in immunosuppression of normal lymphocyte function of cyst fluid. This result is contrary to an earlier observation made by Brooks, et at., 3'4 who demonstrated that mitogen-induced lymphocyte blastogenesis was inhibited with the IgG fraction from the serum of patients with glioblastoma. These authors used DEAE (diethylaminoethyl) cellulose column chromatography and thought that the eluates contained only IgG, as evaluated by both immunoelectrophoresis and immunodiffusion. It is possible, however, that the eluates might have also contained other proteins that could not be detected by such methods. The Protein A used in the current studies reacts in a highly specific fashion with the Fc region of IgG molecules from many species. 9 We determined in our present study that approximately 98% of IgG was removed from the original tumor cyst fluid and that such IgG depletion resulted in a minimal change with regard to the inhibitory activity of cyst fluid on mitogeninduced normal lymphocyte activation. Further characterization of the immunosuppressive factor(s) is needed, since it may give significant insight into understanding the impaired cellular immunity in patients with brain tumors. In particular, in future studies we will attempt to determine whether these factors are produced by the tumor cells, or by lymphoreticular cells that are often present in these tumors. ~
